Western-style diets induce macrophage infiltration and contribute to colitis-associated carcinogenesis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 11, 2010, Pages 1785-1794

  Kim, In Wha ^a,b   Myung, Seung Jae ^a,b   Do, Mi Young ^a   Ryu, Yeon Mi ^a,b   Kim, Mi Jung ^a   Do, Eun Ju ^a,b   Park, Sehan ^a   Yoon, Soon Man ^a   Ye, Byong Duk ^a   Byeon, Jeong Sik ^a   Yang, Suk Kyun ^a   Kim, Jin Ho ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Colitis; Macrophages; Neoplasms; Prostaglandin endoperoxide synthase 2; Western style diet

Indexed keywords

AZOXYMETHANE; BETA CATENIN; DEXTRAN SULFATE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN ENDOPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL INFILTRATION; CELL NUCLEUS; COLITIS; COLON CANCER; COLON CARCINOGENESIS; COLON TUMOR; CONTROLLED STUDY; CYTOPLASM; DIET; DISEASE PREDISPOSITION; DNA BINDING; FOOD INTAKE; INCIDENCE; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN STYLE DIET;

EID: 78149269175     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06332.x     Document Type: Article

References (50)

1. Coleman MP, Quaresma M, Berrino F et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008; 9: 730-56.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin. 2009; 59: 225-49.
3. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J. Clin. 2009; 59: 366-78.
4. Kirk GR, Clements WD. Crohn's disease and colorectal malignancy. Int. J. Clin. Pract. 1999; 53: 314-15.
5. Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol. Clin. N. Am. 1999; 28: 459-77.
6. Cho E, Smith-Warner SA, Spiegelman D et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J. Natl. Cancer Inst. 2004; 96: 1015-22.
7. Newmark HL, Yang K, Lipkin M et al. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 2001; 22: 1871-5.
8. Erdelyi I, Levenkova N, Lin EY et al. Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer. J. Nutr. 2009; 139: 2072-8.
9. Seldenrijk CA, Drexhage HA, Meuwissen SG, Pals ST, Meijer CJ. Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease. Gut 1989; 30: 484-91.
10. Green CE, Liu T, Montel V et al. Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS One 2009; 4: e6713.
11. Jedinak A, Dudhgaonkar S, Sliva D. Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology 2010; 215: 242-9.
12. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004; 431: 405-6.
13. Tanaka S, Tatsuguchi A, Futagami S et al. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut 2006; 55: 54-61.
14. Greenhough A, Smartt HJ, Moore AE et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009; 30: 377-86.
15. Wallace JL. Prostaglandin biology in inflammatory bowel disease. Gastroenterol. Clin. N. Am. 2001; 30: 971-80.
16. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 1997; 57: 3465-70.
17. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008; 99: 1501-6.
18. Boivin GP, Washington K, Yang K et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003; 124: 762-77.
19. Chang WW. Histogenesis of colon cancer in experimental animals. Scand. J. Gastroenterol. Suppl. 1984; 104: 27-43.
20. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993; 69: 238-49.
21. Gosset M, Berenbaum F, Levy A et al. Mechanical stress and prostaglandin E2 synthesis in cartilage. Biorheology 2008; 45: 301-20.
22. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
23. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am. J. Clin. Nutr. 1996; 63: 741-5.
24. Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z. High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin. Exp. Immunol. 2008; 151: 130-8.
25. Nakamura M, Asada M, Matsui H et al. Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites. Clin. Hemorheol. Microcirc. 2006; 34: 193-9.
26. Stevceva L, Pavli P, Husband AJ, Doe WF. The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it. BMC Clin. Pathol. 2001; 1: 3.
27. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7.
28. Popivanova BK, Kostadinova FI, Furuichi K et al. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res. 2009; 69: 7884-92.
29. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004; 4: 71-8.
30. Otani T, Yamaguchi K, Scherl E et al. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 290: G361-8.
31. Melgar S, Drmotova M, Rehnstrom E, Jansson L, Michaelsson E. Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis. Cytokine 2006; 35: 275-83.
32. Feiken E, Romer J, Eriksen J, Lund LR. Neutrophils express tumor necrosis factor-alpha during mouse skin wound healing. J. Invest. Dermatol. 1995; 105: 120-3.
33. Rogler G, Brand K, Vogl D et al. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998; 115: 357-69.
34. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 1998; 42: 477-84.
35. Chang YJ, Wu MS, Lin JT et al. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol. Pharmacol. 2004; 66: 1465-77.
36. Li Q, Withoff S, Verma IM. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol. 2005; 26: 318-25.
37. Greten FR, Eckmann L, Greten TF et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-96.
38. Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res. 2005; 15: 24-7.
39. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am. J. Gastroenterol. 2000; 95: 359-67.
40. Onizawa M, Nagaishi T, Kanai T et al. Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 296: G850-9.
41. Popivanova BK, Kitamura K, Wu Y et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 2008; 118: 560-70.
42. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005; 310: 1504-10.
43. Shao J, Jung C, Liu C, Sheng H. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J. Biol. Chem. 2005; 280: 26565-72.
44. Oguma K, Oshima H, Aoki M et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J. 2008; 27: 1671-81.
45. Fujise T, Iwakiri R, Kakimoto T et al. Long-term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 292: G1150-6.
46. Kaler P, Augenlicht L, Klampfer L. Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 2009; 28: 3892-902.
47. Hanauer SB, Feagan BG, Lichtenstein GR et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-9.
48. Rutgeerts P, Sandborn WJ, Feagan BG et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 2005; 353: 2462-76.
49. Hayakawa Y, Maeda S, Nakagawa H et al. Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis. J. Gastroenterol. 2009; 44: 935-43.
50. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 2007; 7: 139-47.